Azilsartan
Sponsors
Department of Medicine and Bioregulatory SciencesThe University of Tokushima, Graduate School of Health Biosciences, Nishi Mikawa Cardiologist Conference, Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Cardiovascular, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesDepartment of Cardiovascular Medicine, Takeda
Conditions
Blood PressureCovid19Diabetic Kidney DiseaseEssential HypertensionEssential Hypertension Complicated by Type 2 Diabetes MellitusEssential Hypertension With Stable Angina and DyslipidemiaEssential hyertensionEssential hypertension
Phase 2
Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension
CompletedNCT00759551
Start: 2004-08-31End: 2005-06-30Updated: 2010-06-22
Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension
CompletedNCT01289132
Start: 2007-07-31End: 2008-07-31Updated: 2011-02-03
Phase 3
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
NCT02407210
Start: 2015-01-31Target: 304Updated: 2015-04-02
A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension
CompletedNCT02451150
Start: 2015-08-31End: 2015-09-30Updated: 2016-04-07
A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension
CompletedNCT02791438
Start: 2016-08-18End: 2019-06-04Updated: 2020-02-07
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
TerminatedNCT04606563
Start: 2020-10-09End: 2022-04-22Updated: 2023-02-16
Phase 4
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
CompletedNCT01609959
Start: 2012-06-30End: 2013-10-31Updated: 2013-10-30
Medical effects of Azilsartan in patients with hypertension not controlled by other ARBs
Active, not recruitingJPRN-UMIN000010610
Start: 2013-05-01Target: 400Updated: 2025-07-18
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
CompletedNCT02079805
Start: 2014-06-30End: 2016-04-30Updated: 2017-08-02
A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.
WithdrawnNCT02400775
Start: 2015-03-31End: 2016-04-30Updated: 2016-05-24
Unknown Phase
Evaluation for Efficacy and Safety of Azilsartan in Patients with Hypertension
RecruitingJPRN-UMIN000008577
Start: 2012-09-01Target: 30Updated: 2025-07-18
Azilsartan Circadian and Sleep Pressure
CompletedNCT01762501
Start: 2012-12-31End: 2013-12-31Updated: 2015-12-28
AziLsartan treatMent as a swItch strateGy for improvement of uncontrolled Hypertension and blood pressure variabiliTY
Active, not recruitingJPRN-UMIN000012586
Start: 2013-07-01Target: 230Updated: 2025-07-18
Switch from ARB Combination Tablets to Azilsartan: Clinical research on organ protective effect in hypertensive patients living in Okayama
Active, not recruitingJPRN-UMIN000012587
Start: 2012-07-10Target: 100Updated: 2025-07-18
Azilsartan Tablets Special Drug Use Surveillance: Long-term Use
CompletedNCT02092025
Start: 2012-06-20End: 2016-01-15Updated: 2019-01-15
Azilsaltan Tablets (Azilva Tablets) Special Drug Use Surveillance Hypertension Complicated by Diabetes
CompletedNCT02100319
Start: 2014-03-03End: 2016-02-29Updated: 2019-03-21
Azilsartan in Patients With Diabetic Kidney Disease and Hypertension
NCT05753696
Start: 2023-04-01End: 2024-12-30Target: 106Updated: 2023-03-03